Tyche Industries Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 987502,
    "name": "Tyche Industries",
    "stock_name": "Tyche Industries",
    "full_name": "Tyche Industries Ltd",
    "name_url": "stocks-analysis/tyche-industries",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "109.00",
    "chg": 3,
    "chgp": "2.83%",
    "dir": 1,
    "prev_price": "106.00",
    "mcapval": "111.72 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532384,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 11,
    "indexname": "India SENSEX",
    "isin": "INE443B01012",
    "curr_date": "Mar 24",
    "curr_time": "",
    "bse_nse_vol": "4.58 k",
    "exc_status": "Active",
    "traded_date": "Mar 24, 2026",
    "traded_date_str": "2026 03 24",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tyche-industries-987502-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Tyche Industries Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tyche-industries-ltd-valuation-shifts-signal-heightened-price-risk-amid-sector-challenges-3909082",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TycheIndustries_valuationdot_3909082.png",
        "date": "2026-03-24 08:01:47",
        "description": "Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters deteriorate sharply, with its price-to-earnings (P/E) ratio and price-to-book value (P/BV) signalling a shift from expensive to very expensive territory. This re-rating comes amid subdued financial performance and a challenging sector backdrop, raising concerns about the stock’s price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Tyche Industries Ltd Valuation Shifts Signal Price Attractiveness Change Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tyche-industries-ltd-valuation-shifts-signal-price-attractiveness-change-amid-sector-challenges-3897942",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TycheIndustries_valuationdot_3897942.png",
        "date": "2026-03-18 08:00:59",
        "description": "Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change accompanies a downgrade in its Mojo Grade to Strong Sell, reflecting growing concerns over its price attractiveness relative to historical and peer benchmarks."
      },
      {
        "title": "Tyche Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tyche-industries-ltd-is-rated-strong-sell-3892097",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TycheIndustries_mojoScore_3892097.png",
        "date": "2026-03-15 10:10:23",
        "description": "Tyche Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Tyche Industries Ltd Valuation Shifts Signal Price Attractiveness Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tyche-industries-ltd-valuation-shifts-signal-price-attractiveness-decline-3884298",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TycheIndustries_valuationdot_3884298.png",
        "date": "2026-03-11 08:01:06",
        "description": "Tyche Industries Ltd, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions and impacts the stock's price attractiveness amid a challenging industry backdrop and mixed financial metrics."
      },
      {
        "title": "Tyche Industries Ltd Valuation Shifts Signal Heightened Price Caution",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tyche-industries-ltd-valuation-shifts-signal-heightened-price-caution-3872557",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TycheIndustries_valuationdot_3872557.png",
        "date": "2026-03-05 08:01:37",
        "description": "Tyche Industries Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, prompting a downgrade in its Mojo Grade to Strong Sell. With its price-to-earnings (P/E) ratio easing from very expensive to merely expensive, alongside a subdued return profile compared to the Sensex, investors are urged to reassess the stock’s price attractiveness amid evolving market dynamics."
      },
      {
        "title": "Tyche Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tyche-industries-ltd-is-rated-strong-sell-3866243",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TycheIndustries_mojoScore_3866243.png",
        "date": "2026-03-03 10:10:23",
        "description": "Tyche Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Tyche Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tyche-industries-ltd-is-rated-strong-sell-3848081",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TycheIndustries_mojoScore_3848081.png",
        "date": "2026-02-20 10:10:49",
        "description": "Tyche Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Tyche Industries Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tyche-industries-ltd-valuation-shifts-signal-heightened-price-risk-amid-sector-challenges-3841747",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TycheIndustries_valuationdot_3841747.png",
        "date": "2026-02-16 08:05:28",
        "description": "Tyche Industries Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen a marked shift in its valuation parameters, moving from fair to very expensive territory. This change, coupled with a recent downgrade to a Strong Sell rating, highlights growing concerns about the stock’s price attractiveness relative to its historical and peer benchmarks."
      },
      {
        "title": "Are Tyche Industries Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-tyche-industries-ltd-latest-results-good-or-bad-3840546",
        "imagepath": "",
        "date": "2026-02-14 19:54:55",
        "description": "Tyche Industries Ltd's latest financial results for the quarter ended December 2025 reveal significant challenges in its operational performance. The company reported net sales of ₹10.58 crores, marking a decline of 25.28% compared to the previous quarter and a substantial 40.39% year-on-year decrease. This quarter represents the lowest revenue figure in recent history, indicating a troubling trend of declining demand and potential loss of market share in its core pharmaceutical intermediates business.\n\nNet profit for the quarter stood at ₹1.82 crores, reflecting a year-on-year decline of 61.60% and a sequential decline of 19.78%. The operating margin, excluding other income, fell to 10.30%, down from 27.27% in the same quarter last year, highlighting a significant compression in profitability. The company's reliance on non-operating income is concerning, as it constituted a large portion of profit before t..."
      }
    ],
    "total": 130,
    "sid": "987502",
    "stock_news_url": "https://www.marketsmojo.com/news/tyche-industries-987502"
  },
  "announcements": [
    {
      "caption": "Disclosures Under Reg. 10(6) Of SEBI (SAST) Regulations 2011",
      "datetime": "20-Mar-2026",
      "details": "Disclosure under Regulation 10(6) of SEBI(Substantial Acquisition of Shares & Takeovers) Regulations 2011 for G Ganesh Kumar",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "20-Mar-2026",
      "details": "Enclosed the Disclosure under Regulation 10(6) of SEBI(SAST) Regulations 2011",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
      "datetime": "20-Mar-2026",
      "details": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for G Ganesh Kumar",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Tyche Industries Ltd has declared <strong>30%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Tyche Industries Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Challenges

2026-03-24 08:01:47

Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters deteriorate sharply, with its price-to-earnings (P/E) ratio and price-to-book value (P/BV) signalling a shift from expensive to very expensive territory. This re-rating comes amid subdued financial performance and a challenging sector backdrop, raising concerns about the stock’s price attractiveness relative to peers and historical benchmarks.

Read full news article

Tyche Industries Ltd Valuation Shifts Signal Price Attractiveness Change Amid Sector Challenges

2026-03-18 08:00:59

Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change accompanies a downgrade in its Mojo Grade to Strong Sell, reflecting growing concerns over its price attractiveness relative to historical and peer benchmarks.

Read full news article

Tyche Industries Ltd is Rated Strong Sell

2026-03-15 10:10:23

Tyche Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Tyche Industries Ltd Valuation Shifts Signal Price Attractiveness Decline

2026-03-11 08:01:06

Tyche Industries Ltd, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions and impacts the stock's price attractiveness amid a challenging industry backdrop and mixed financial metrics.

Read full news article

Tyche Industries Ltd Valuation Shifts Signal Heightened Price Caution

2026-03-05 08:01:37

Tyche Industries Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, prompting a downgrade in its Mojo Grade to Strong Sell. With its price-to-earnings (P/E) ratio easing from very expensive to merely expensive, alongside a subdued return profile compared to the Sensex, investors are urged to reassess the stock’s price attractiveness amid evolving market dynamics.

Read full news article

Tyche Industries Ltd is Rated Strong Sell

2026-03-03 10:10:23

Tyche Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Tyche Industries Ltd is Rated Strong Sell

2026-02-20 10:10:49

Tyche Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Tyche Industries Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Challenges

2026-02-16 08:05:28

Tyche Industries Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen a marked shift in its valuation parameters, moving from fair to very expensive territory. This change, coupled with a recent downgrade to a Strong Sell rating, highlights growing concerns about the stock’s price attractiveness relative to its historical and peer benchmarks.

Read full news article

Are Tyche Industries Ltd latest results good or bad?

2026-02-14 19:54:55

Tyche Industries Ltd's latest financial results for the quarter ended December 2025 reveal significant challenges in its operational performance. The company reported net sales of ₹10.58 crores, marking a decline of 25.28% compared to the previous quarter and a substantial 40.39% year-on-year decrease. This quarter represents the lowest revenue figure in recent history, indicating a troubling trend of declining demand and potential loss of market share in its core pharmaceutical intermediates business. Net profit for the quarter stood at ₹1.82 crores, reflecting a year-on-year decline of 61.60% and a sequential decline of 19.78%. The operating margin, excluding other income, fell to 10.30%, down from 27.27% in the same quarter last year, highlighting a significant compression in profitability. The company's reliance on non-operating income is concerning, as it constituted a large portion of profit before t...

Read full news article

View All News